Clinical Trial Update: Specified Drug Use Survey on AJOVY Subcutaneous Injection for Long-term Use

View source ↗

Summary

A clinical trial update notes a specified drug-use survey evaluating long-term subcutaneous AJOVY (fremanezumab) use for migraine, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Ajovy (fremanezumab)

Snippet

Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Migraine Disorders | Status: RECRUITING